Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: an Open-Label, Phase 1 Study
Journal of immunotherapy and precision oncology（2025）
关键词
immune checkpoint inhibitor,programmed cell death (pd-1),refractory cholangiocarcinoma,safety,anti-tumor activity
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要